Abstract

The changing dynamics of warfare today has been a vulnerable matter of concern. The rapid advancements in technology such as synthetic biology and genetic engineering is changing the global landscape. Use of AI enables design, modification and production of novel pathogens. Even though biotechnology holds immense promises, it’s dual use also proposes potential threats by producing more antimicrobial resistant pathogens as well as the complete new form of deadliest viruses using synthetic biotechnology. This poses significant national biosecurity concerns. This paper examines how synthetic biology and genetic engineering with the addition of AI concerning the development of potential bioweapons. This paper also analyses current global norms and India’s capabilities, vulnerabilities and technological infrastructure that could be exploited in a high-impact biological incident along with policy framework suggestions which aim at strengthening national biodefence. In doing so, it underscores the urgent need for India to modernise its biosecurity architecture to safeguard its public health, economic stability and national security in the age of advanced biotechnology.

Key Words: Biotechnology, Synthetic Biology, Genetic Engineering, Global Biosecurity, Bioweapons

Overview of Genetic Engineering and Synthetic Biology

Genetic engineering and synthetic biology represent the most transformative development in the life sciences which enables precise manipulation, design and accurate construction of biological systems. While these technologies have generated significant benefits in medicine, agriculture and industry, they also possess significant threat due to their dual use for the development of potential bioweapons which leads to emergence of national biosecurity concerns.

Genetic Engineering refers to the deliberate modification of an organism's genetic material using biotechnological tools to alter specific traits or functions. Traditional techniques involved recombinant DNA technology, where genes from one organism were inserted into another to express desired characteristics. Over time, advancements such as site-directed mutagenesisi and, more recently, CRISPR-Cas systems have made genetic modification faster, cheaper, and far more precise. These developments allow scientists to edit genes with high accuracy, raising both the therapeutic potential and the risk of misuse.

Synthetic biology extends beyond genetic engineering by aiming to design and construct new biological components, pathways, or entire organisms that may not exist in nature. It applies engineering principles such as standardization, modularity, and predictability to biology. Synthetic biology enables the de novo synthesis of genetic sequences, redesign of microbial genomes, and creation of novel biological functions. The convergence of synthetic biology with artificial intelligence, automation, and high-throughput DNA synthesis has accelerated innovation while simultaneously lowering barriers to entry. (National Human Genome Research Institute, 2019)

The dual-use nature of both fields lies in the fact that the same tools used for beneficial purposes such as vaccine development, disease diagnostics, and sustainable bio-manufacturing can also be repurposed to enhance pathogenicity, transmissibility, or resistance to medical countermeasures. As access to genetic engineering tools and synthetic biology platforms expands globally, the distinction between legitimate research and potential misuse becomes increasingly difficult to regulate.The dual-use nature of both fields lies in the fact that the same tools used for beneficial purposes such as vaccine development, disease diagnostics, and sustainable bio-manufacturing can also be repurposed to enhance pathogenicity, transmissibility, or resistance to medical countermeasures. As access to genetic engineering tools and synthetic biology platforms expands globally, the distinction between legitimate research and potential misuse becomes increasingly difficult to regulate.

In the context of biological warfare, these technologies have altered the threat landscape by enabling the possibility of engineered or modified biological agents that may evade traditional detection and response mechanisms. Consequently, genetic engineering and synthetic biology now occupy a central position in contemporary biosecurity and biodefense discourse, necessitating robust governance, ethical oversight, and international cooperation particularly for countries like India that are rapidly expanding their biotechnology capabilities.

Applications of These Technologies in the Development of Potential Biological Weapons

As mentioned earlier, Genetic Engineering and Synthetic Biology is actually developed for beneficial purposes like in medicine, agriculture and industry, but their significant dual use risk makes us worried about the development of novel bioweapons. New emerging technologies lower the technical barriers, increase precision and expand the range of biological agents that could be deliberately manipulated for hostile purposes.

Genetic Modification of Existing Pathogens- This is one of the major areas of concern as, advances in gene editing allows the alterations that may enhance the virulence, transmissibility, environmental stability and resistance to medical countermeasures. Such modifications could undermine established public health defences, including vaccines and therapeutics thereby, complicating detection, diagnosis and responses. Many labs conduct gain of functionii research. The idea is to study how dangerous viruses evolve so that the vaccines and defenses can be prepared.

De Novo Synthesis of Biological Agents- The generation of complete novel viruses is now possible by synthetic biotechnology. This technology eliminates access to naturally occurring pathogens. This technology enables the chemical synthesis of genetic sequences and it is theoretically possible to recreate known pathogenic organisms and design complete novel biological entities with unpredictable characteristics which leads to lack of medicinal production and supply to strong resistant viruses as their source is not knowniii.

Manipulation of Host-Pathogen Interaction- Genetic tools can be used to study and alter how pathogen interacts with the human immune system. It results in enabling immune evasion and prolonged infection. In a hostile context, this knowledge could be exploited to design agents that delay immune recognitioniv or reduce the effectiveness of standard treatments.

Targeted or Population Specific Effects- Synthetic Biology also introduces risk related to targeted or population specific effects, although highly speculative and ethically condemned, research into genetic variability across populations raises concerns that biological agents can be engineered to exploit specific biological susceptibilities. Even the perception of such possibilities has strategic and psychological implications for national and international security.

Agro-Biological Warfare- Beyond human health, these technologies can be misused in agriculture which will be commonly called Agro-Biowarfare. It will target crops or livestock critical to food security and economic stability. Genetically engineered plant or animal pathogens could cause widespread destruction without immediate detection, blurring the line between natural outbreaks and deliberate attacks. (Biosecurity in the Age of Synthetic Biology: Safeguarding against Emerging Risks | Taylor’s University, 2024)

Most importantly many of these applications do not require state level resources. The democratization of biotechnology, including reduced costs, open access scientific information and the proliferation of private and academic laboratories increases the risk of misuse by non-state actors. This evolving threat landscape challenges existing regulatory and surveillance mechanisms. Overall, while genetic engineering and synthetic biology are transformative fields, their potential application in the development of biological weapons underscores the urgent need for robust biosecurity frameworks, ethical oversight and international cooperation to prevent misuse while preserving scientific progress.

Global Trends in the Advancement and Use of Genetic Engineering and Synthetic Biology

1. Rapid Market Growth and Technological Expansion- The global synthetic biological sector is expanding quickly and reducing the cost of DNA sequencingv and synthesis, rising adoption across industries like health, agriculture, and environmental applications, and the integration of advanced tools such as AI and machine learning. (Research and Markets, 2025)

2. Emerging Dual- Use Biosecurity Concerns- while as mentioned above, synthetic biology and genetic engineering holds immense promise, they also introduce potential dual-use risks. There is increasing international emphasis on managing the potential misuse of these technologies, including unintended or intended consequences and deliberate weaponisation.

(Biosecurity in the Age of Synthetic Biology: Safeguarding against Emerging Risks | Taylor’s University, 2024) There was a small example of how the government can control the experiments and research if they find a possible danger. Between 2011-2014, some American labs modified H5N1 influenza virus to make them more transmissible. In 2014, the US government announced a moratorium on funding of various ‘Gain of Function' experiments involving Influenza, SARS and MERS. The importance of this case is

● Scientific freedom is not absolute.

● A democracy can pause its own research when risk outweighs benefits.

● Ethical oversight and public accountability can influence national biosecurity policy.

3. Increased accessibility and democratization of tools- The technology is becoming more accessible due to the growth of DIY biology movements, low-cost gene editing tools, and widespread distribution of genetic data, raising concerns about governance gaps and uneven safety practices across borders.

4. Policy and Regulatory Debates Worldwide- Governments and international bodies are actively discussing frameworks for biosecurity, biosafety, and governance of synthetic biology research. These discussions aim to balance innovation with risk mitigation while addressing ethical, legal, and social implications.

5. Regional Research and Collaboration Dynamics- Countries like the United States, China, Japan, Australia, and India are increasing their research output in synthetic biology and related technologies. Collaborative research and strategic partnerships between nations are becoming more common, highlighting both competitive and cooperative dimensions in global biotechnology development. (Asia, 2025)

Assessment of India’s Current Capabilities, Vulnerabilities, and Preparedness

India has taken several steps toward strengthening its capacity to respond to biological threats, including those arising from misuse of genetic engineering and synthetic biology. However, preparedness remains uneven and fragmented due to institutional, infrastructural, and strategic gaps.

Current Capabilities

● India operates a nationwide surveillance system, the Integrated Disease Surveillance Programme (IDSP) covering most districts and facilitating early detection of infectious disease patterns.

● India has multiple Biosafety Level (BSL) laboratories, including BSL-3 facilities and at least one BSL-4 facility at the National Institute of Virology in Pune. Plans are underway to upgrade other institutes to BSL-4 standards, such as NIHSAD in Bhopal. (TNN, 2025)

● The National Disaster Response Force (NDRF) has received training specifically for biological disasters, guided by NDMA protocols, and workshops have been conducted to improve interdisciplinary response. (National Workshop on Enhancing Response Capabilities in Biological Disasters | NDRF - National Disaster Response Force, 2015)

Vulnerabilities

● Multiple ministries and agencies (e.g., DBT, DRDO, ICMR, MoHFW) manage different aspects of biosafety and biodefense without a central coordinating authority, leading to siloed decision-making and delayed responses. (Goswami, 2025)

● India lacks a dedicated, updated legal framework specifically targeting modern biothreats and dual-use risks posed by advanced biotechnology. Existing laws were created before recent leaps in synthetic biology and may not adequately govern their misuse.

● Although India has some high-containment labs, their distribution is uneven, and overall capacity for advanced pathogen research, containment, and rapid analysis remains limited compared to needs for deliberate or engineered threats.

● Large population density, particularly in rural areas, combined with variable healthcare capacity, means that disease outbreaks whether natural or engineered can spread rapidly and overwhelm local systems. India’s urban and rural health infrastructure is uneven, posing a challenge for rapid, coordinated response.

Preparedness Efforts

● The National Disaster Management Authority (NDMA) has published guidelines for biological disasters, and state governments are developing emergency action plans and simulations to improve readiness.

● India is a signatory to the Biological Weapons Convention (BWC) and participates in export control regimes like the Australia Group. Senior leaders have advocated for modernizing global biosecurity frameworks and stronger compliance mechanisms.

● Experts and policymakers have underscored the need for a national biosecurity strategy with unified governance, enhanced surveillance systems, rapid response teams, and investment in advanced diagnostic technologies to bridge current preparedness gaps.

India’s Emerging Security Challenges in the Context of Advanced Biotechnologies

The rapid advancement of genetic engineering and synthetic biology presents a complex set of emerging security challenges for India. While these technologies are essential for innovation in healthcare, agriculture, and industry, their dual-use nature introduces new risks that extend beyond traditional biological threats.

One of the foremost challenges is the increased accessibility of advanced biotechnological tools. The declining cost of DNA synthesis, gene-editing platforms, and bioinformatics software has lowered barriers to entry, making it possible for non-state actors or poorly regulated entities to misuse these technologies. This diffusion of capability complicates attribution and detection of deliberate biological misuse.

India also faces institutional and governance challenges. Oversight of biotechnology research and applications is distributed across multiple ministries and regulatory bodies, often resulting in fragmented governance. Existing biosafety and biosecurity regulations were largely designed for conventional biological risks and may not be fully equipped to address threats arising from synthetic biology, such as engineered pathogens or novel biological constructs. (Emerging Challenges to Biological Security | National Institute of Advanced Studies, 2025)

Another significant concern is public health system vulnerability. High population density, rapid urbanization, and disparities in healthcare infrastructure can amplify the impact of a deliberate or accidental biological release. An engineered pathogen with enhanced transmissibility or resistance could overwhelm surveillance, diagnostic, and response mechanisms before effective containment measures are implemented.

Agro-biosecurity represents an additional and often underestimated challenge. India’s dependence on agriculture and livestock for food security and livelihoods makes it vulnerable to biological threats targeting crops or animals. Advances in biotechnology could enable the development of agents designed to selectively damage agricultural systems, causing economic disruption without immediate human casualties. (Emerging Challenges to Biological Security | National Institute of Advanced Studies, 2025)

Finally, strategic and geopolitical dimensions add to India’s security concerns. Global competition in advanced biotechnologies, uneven regulatory standards across countries, and the absence of robust international verification mechanisms under existing treaties increase uncertainty. India must navigate a landscape where rapid scientific progress is occurring alongside weak global enforcement against biological weaponization. (Emerging Challenges to Biological Security | National Institute of Advanced Studies, 2025)

Collectively, these challenges highlight the need for India to view advanced biotechnologies not only as drivers of growth but also as critical components of national security, requiring integrated policy responses, strengthened governance, and sustained investment in preparedness and resilience.

Recommended Policy and Regulatory Frameworks for Strengthening National Biosecurity

1. Strengthening Biological Weapons Convention(BWC) would be one of the most crucial steps as BWC prohibits development, production and stockpiling of bioweapons and is the cornerstone of global biosecurity. India supports modernizing BWC with stronger compliance and verification mechanisms to address emerging biosecurity challenges. But the main concern is that even though BWC was established but due to lack of verification and implementation it merely remained on the papers it seems. It needs strong verification as well as implementation.

2. Looking at India, there is a strong need to form a ‘National Biosecurity Framework’ or ‘National Biosecurity Policy’ as we should not ignore the biological threats in the age of non-conventional warfare. India has already proposed the ‘National Implementation Framework’ that included oversight of dual-use research, reporting mechanisms, and incident management which are keys to regulate advanced biotechnologies domestically. (Strengthening Global Biosecurity and Modernising the Biological Weapons Convention (BWC), 2025)

3. Contemporary biosecurity scholarship emphasizes that traditional, static regulatory approaches are insufficient to manage the rapidly evolving risks associated with synthetic biology and advanced genetic engineering. Experts advocate adaptive governance systems that can evolve alongside technological advancements, allowing policies to be periodically revised in response to new scientific capabilities and threat perceptions. A tiered risk-assessment framework is recommended, wherein biological research and applications are classified based on their potential for misuse, scale of impact, and reversibility. Such an approach enables regulators to allocate oversight resources proportionately, rather than applying uniform restrictions that may hinder legitimate research. (Frontiers, 2024)

4. India’s Draft National Biotechnology Development Strategy 2020–25 reflects an effort to align scientific innovation with national priorities, including safety, sustainability, and security. The strategy emphasizes the development of robust biotechnology infrastructure networks, enhanced research capacity, and improved coordination between academic, industrial, and governmental actors. Importantly, the policy highlights the need for responsible data sharing and governance of biological information, acknowledging the growing role of genomic data and digital platforms in biotechnology research. Provisions related to molecular surveillance and translational researchvi are particularly relevant from a biosecurity perspective, as they can strengthen early detection of biological threats while supporting public-health preparedness.

5. The Cartagena Protocol on biosafety represents a precautionary international approach to managing risks associated with modern biotechnology, particularly genetically modified organisms. Its core objective is to ensure the safe handling, transfer, and use of living modified organisms that may have adverse effects on biodiversity and human health. While the protocol is primarily environmental in focus, its principles are indirectly relevant to biosecurity governance. The emphasis on risk assessment, prior informed consent, transparency, and international cooperation provides valuable normative guidance for regulating emerging biotechnologies.

6. Multi-stakeholder dialogue platforms play a critical role in bridging gaps between scientific innovation and security governance. Initiatives such as the Biosecurity Dialogues facilitate structured engagement among governments, scientific communities, industry leaders, and civil society actors. These forums help build shared norms, promote transparency, and encourage responsible conduct in life-science research. They also enable early identification of emerging risks and support coordinated responses across sectors and borders. Such platforms are particularly valuable in addressing the transnational nature of biosecurity threats.(Biosecurity Dialogues, 2025)

7. Australia’s Biosecurity Act 2015 represents a comprehensive, risk-based legislative approach to managing biological threats affecting human, animal, and plant health. The law integrates prevention, preparedness, detection, and response under a single statutory framework. It emphasizes proportional risk assessment, inter-agency coordination, and emergency powers during biological incidents. For countries like India, the Act offers useful lessons on unified governance, legal clarity, and adaptive regulatory mechanisms suitable for evolving biotechnological risks.

Conclusion

The convergence of genetic engineering and synthetic biology has fundamentally altered the nature of biological threats, expanding both the scale and sophistication of potential biowarfare. While these technologies hold immense promise for healthcare, agriculture, and sustainable development, their dual-use nature poses serious challenges to national and global security. For India, a rapidly advancing biotechnology ecosystem combined with demographic, infrastructural, and governance complexities increases vulnerability to deliberate or accidental biological incidents.

India has demonstrated important capabilities through disease surveillance systems, laboratory networks, and international commitments such as the Biological Weapons Convention. However, gaps persist in unified biosecurity governance, regulatory oversight of emerging technologies, and preparedness for highly engineered biological threats. Addressing these challenges requires moving beyond reactive public-health responses toward a proactive, security-oriented biosecurity framework.

Strengthening national biosecurity will depend on adaptive regulatory systems, coordinated civil-military mechanisms, sustained investment in scientific infrastructure, and continuous risk assessment of dual-use research. Equally important is India’s engagement in international dialogue and norm-building efforts to modernize global biosecurity governance. Ultimately, safeguarding India against future biological threats will require balancing innovation with responsibility, ensuring that advances in biotechnology contribute to national resilience rather than strategic vulnerability.

Endnotes

i. Site directed mutagenesis is a powerful molecular biological technique to create specific, intentional changes (mutations) in DNA sequence like single base pair substitutions, insertions or deletions using custom synthesized primers in Polymerase Chain Reaction (PCR). This method allows researchers to precisely alter genes to study protein function, understand genetic diseases and engineer proteins with improved or novel properties becoming a cornerstone of modern genetics and biotechnology.

ii. Gain of Function is intentional enhancement of viruses and modifying their existing genetic material to make them more transmissible, more potent and more resistant to many strong antiviral drugs which ultimately make them more deadly.

iii. Vaccines are medicines prepared from the virus strains to prevent disease. Methods involve using the whole virus, part of the virus or the genetic material of the virus. So the complete new strain produced using synthetic biotechnology makes it difficult for scientists to detect and make antiviral drugs.

iv. Immune recognition is a fundamental process where your body identifies what’s self (your own cells) versus non-self (foreign invaders like bacterias, viruses, toxins) using specialized molecules, triggering a defence response to neutralize threats while avoiding attacking healthy tissues.

v. DNA sequencing is the lab process of reading the exact order of the four chemical (Nitrogen) bases i.e. A,T,G,C( Adenine, Thymine, Guanine, Cytocine) in a DNA molecule, revealing the genetic instructions that tell cells how to function and grow which is crucial for understanding genetics.

vi. Molecular Surveillance is the use of molecular biology techniques such as DNA sequencing and gene expression analysis to study and monitor diseases particularly pathogens and cancers. This approach aims to understand the molecular mechanism underlying disease, identify specific subtype or mutations

References

Asia. (2025, February 19). Synthetic Biology in Australia, China, and India: Insights from Asia and Pacific Research Center, Japan Science and Technology Agency. Prnewswire.com; Cision PR Newswire. https://www.prnewswire.com/news-releases/synthetic-biology-in-australia-china-and-india-insights-from-asia-and-pacific-research-center-japan-science-and-technology-agency-302378929.html

Biosecurity Dialogues. (2025, November 5). The Nuclear Threat Initiative. https://www.nti.org/about/programs-projects/project/global-biosecurity-dialogue

Biosecurity in the Age of Synthetic Biology: Safeguarding Against Emerging Risks | Taylor’s University. (2024). Taylor’s University. https://university.taylors.edu.my/en/student-life/news/2024/biosecurity-in-the-age-of-synthetic-biology-safeguarding-against-emerging-risks.html

Emerging Challenges to Biological Security | National Institute of Advanced Studies. (2025). Nias.res.in. https://cms.nias.res.in/events/emerging-challenges-to-biological-security

Frontiers. (2024). Frontiers | Peer Reviewed Articles - Open Access Journals. Frontiers. https://www.frontiersin.org/

Genetic Engineering. (2025). Genome.gov. https://www.genome.gov/genetics-glossary/Genetic-Engineering

Goswami, A. (2025, August 23). Bioterrorism and India’s Security Framework: Aligning National Law with Global Norms - Defence Research and Studies. Defence Research and Studies. https://dras.in/bioterrorism-and-indias-security-framework-aligning-national-law-with-global-norms/

https://www, & book.com/unep. (2019). Risks and potential rewards of synthetic biology. UNEP. https://www.unep.org/index.php/news-and-stories/story/risks-and-potential-rewards-synthetic-biology

National Human Genome Research Institute. (2019, August 14). Synthetic Biology. Genome.gov; National Human Genome Research Institute. https://www.genome.gov/about-genomics/policy-issues/Synthetic-Biology

National Workshop on Enhancing Response Capabilities in Biological Disasters | NDRF - National Disaster Response Force. (2015). Ndrf.gov.in. https://www.ndrf.gov.in/en/pressrelease/national-workshop-enhancing-response-capabilities-biological-disasters

Office, U. S. G. A. (2023, April 17). Science & Tech Spotlight: Synthetic Biology | U.S. GAO. Www.gao.gov. https://www.gao.gov/products/gao-23-106648

Research and Markets. (2025, July 18). Global Synthetic Biology Market Research 2026-2036 | Technology Roadmap Highlights Future of Space Biotech, AI Convergence, and Global Market Democratization. GlobeNewswire News Room; GlobeNewswire. https://www.globenewswire.com/news-release/2025/07/18/3117805/28124/en/Global-Synthetic-Biology-Market-Research-2026-2036-Technology-Roadmap-Highlights-Future-of-Space-Biotech-AI-Convergence-and-Global-Market-Democratization.html

Rugnetta, M. (2016, April 20). Synthetic biology. Encyclopedia Britannica. https://www.britannica.com/science/synthetic-biology

Srinivas, K. (n.d.). Synthetic Biology in India: Issues in Risk, Power and Governance. Retrieved December 18, 2025, from https://www.ris.org.in/sites/default/files/Publication/DP%20194%20Ravi%20Srinivas.pdf

Strengthening Global Biosecurity and Modernising the Biological Weapons Convention (BWC). (2025, December 2). Current Affairs - next IAS. https://www.nextias.com/ca/current-affairs/02-12-2025/global-biosecurity-modernising-bwc

The. (1998, July 20). Genetic engineering | Definition, Process, Uses, Examples, Techniques, & Facts. Encyclopedia Britannica. https://www.britannica.com/science/genetic-engineering

TNN. (2025, June 23). NIHSAD to be upgraded to BSL-4 lab for testing deadly pathogens. The Times of India; The Times Of India. https://timesofindia.indiatimes.com/city/bhopal/nihsad-to-be-upgraded-to-bsl-4-lab-for-testing-deadly-pathogens/articleshow/122032582.cms